Repligen (RGEN) EBIT Growth (3y) (2013 - 2026)
Repligen (RGEN) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 28.02% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.49% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -73.35% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 17.69% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -0.62% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -24.29% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -32.42% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 145.32% |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | -10.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.17% |
| Mar 31, 2026 | 4.78% |
| Dec 31, 2025 | -28.48% |
| Sep 30, 2025 | -31.64% |
| Jun 30, 2025 | -39.63% |
| Mar 31, 2025 | -52.14% |
| Dec 31, 2024 | -43.83% |
| Sep 30, 2024 | -29.53% |
| Jun 30, 2024 | -51.60% |
| Mar 31, 2024 | -53.11% |
| Dec 31, 2023 | -17.24% |
| Sep 30, 2023 | -39.29% |
| Jun 30, 2023 | -0.44% |
| Mar 31, 2023 | 5.19% |
| Dec 31, 2022 | 102.35% |
| Sep 30, 2022 | 87.70% |
| Jun 30, 2022 | 78.78% |
| Mar 31, 2022 | 75.13% |
| Dec 31, 2021 | 68.29% |
| Sep 30, 2021 | 78.95% |